|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| G01N 33/574 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C12Q 1/68 | (2018.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 35/17 | (2015.01) | ||
| A61K 35/15 | (2015.01) | ||
| G16B 30/00 | (2019.01) | ||
| G16B 40/00 | (2019.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3347039 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16763526.7 |
| Date of filing the European patent application | 2016-09-12 | |
| (97) | Date of publication of the European application | 2018-07-18 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/071471 |
| Date | 2016-09-12 |
| (87) | Number | WO 2017/042394 |
| Date | 2017-03-16 |
| (30) | Number | Date | Country code |
| 201516047 | 2015-09-10 | GB |
| (72) |
MCGRANAHAN, Nicholas , GB
ROSENTHAL, Rachel , GB
SWANTON, Charles , GB
PEGGS, Karl , GB
QUEZADA, Sergio , GB
|
| (73) |
Cancer Research Technology Limited ,
2 Redman Place, London E20 1JQ,
GB
|
| (54) | "IMMUNE CHECKPOINT INTERVENTION" IN CANCER |
| "IMMUNE CHECKPOINT INTERVENTION" IN CANCER |